F-group (family)

2003.1.5.65 DOT1

Ligands and drugs

117
Member domains
64
with ligand contacts (≤ 4 Å)
54.7% of members
60
with DrugDomain annotations
51.3% of members
37
with a DrugBank compound
31.6% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 2003.1.5.65 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00118SAMAdemetionine11
DB01752SAHS-adenosyl-L-homocysteine8
DB00640ADNAdenosine2
DB09459TLAL-tartaric acid2
DB046045ID5-iodotubercidin1
DB12920EP6Pinometostat1

Most frequently bound compounds

PDB ligandNameDomains in contact
SAMS-ADENOSYLMETHIONINE12
SAHS-ADENOSYL-L-HOMOCYSTEINE11
UNXUNKNOWN ATOM OR ION7
KmetalPOTASSIUM ION6
5JJN~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine4
0QK7-{5-[(3-{[(4-tert-butylphenyl)carbamoyl]amino}propyl)(propan-2-yl)amino]-5-deoxy-beta-D-ribofuranosyl}-7H-pyrrolo[2,3-d]pyrimidin-4-amine3
CAmetalCALCIUM ION3
5EG2-({5-[(2-chlorophenoxy)methyl]-1H-tetrazol-1-yl}acetyl)-N-(4-chlorophenyl)hydrazinecarboxamide2
5EKN-[1-(2-chlorophenyl)-1H-indol-6-yl]-2-{[5-(2-chlorophenyl)-1H-tetrazol-1-yl]acetyl}hydrazinecarboxamide2
5EVN~4~-methyl-N~2~-[2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl]pyrimidine-2,4-diamine2
5EW6'-chloro-1,4-dimethyl-5'-(2-methyl-6-{[4-(methylamino)pyrimidin-2-yl]amino}-1H-indol-1-yl)-3,3'-bipyridin-2(1H)-one2
5F44-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrrole-2-carboxamide2
5F6(2,6-dichlorophenyl)(quinolin-6-yl)methanone2
5F7N-(2,6-dichlorophenyl)-4-methoxy-N-methylquinolin-6-amine2
5JT(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine2
5JUN~2~-{[2-chloro-3-(2-methylpyridin-3-yl)-1-benzothiophen-5-yl]carbamoyl}-N-(3-{methyl[(3R)-1-(5H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]amino}propyl)glycinamide2
ADNADENOSINE2
N4W~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine2
N4Z~{N}1-[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]-~{N}2-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonyl-benzene-1,2-diamine2
N5K3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide2